₹ 354.70
2.90 (0.82%)
B
Biocon
₹ 354.70
Biocon Share Price Today
Biocon (BIOCON) share price is trading at ₹354.70 on the NSE as of November 2, 2026 at 03:55 PM, up by 0.82% from its previous close of ₹351.80. In todays trading session BIOCON reached a high of 358.00 and low of 351.50. The average traded price for today is 354.86. The 50 DMA stands at 376.88 and 200 DMA is at 390.73. Looking at intraday trend, the stock is moving sideways.
Stock Overview
- Symbol : BIOCON
- Open : ₹354.70
- Previous Close : ₹351.80
- Day's Range : ₹351.50 – ₹358.00
- 52-Week Range : ₹318.40 – ₹447.15
- Upcoming Event : Q2 FY 26-27 Results (4th Nov 2026, Wednesday)
Get 20+ Chart Types, 180+ Indicators, 80+ Drawing Tools & Create Custom Indicators for FREE.
BIOCON Stock Performance
Markets Today
High
358.00
Low
351.50
Open at
354.70
Prev Close
351.80
Volumes
21,74,472
Avg Price
354.86
Lower Circuit
319.25
Upper Circuit
390.15
Last Traded Details
Quantity
2
Time
15:55:01
Price Movement
Historical Performance
3 M High
442.50
3 M Low
318.40
1 Yr High
447.15
1 Yr Low
318.40
3 Yr High
447.15
3 Yr Low
217.50
5 Yr High
447.15
5 Yr Low
191.55
1-Year Performance
BIOCON Pros and Cons
Consolidated revenue grows from ₹4,022 Cr to ₹4,391 Cr from Q1 FY26 to Q1 FY27, maintaining steady top-line scale.
Consolidated net profit before exceptional items rises from ₹31 Cr to ₹145 Cr from Q1 FY26 to Q1 FY27, showing resilient core earnings.
Generics EBITDA margin recovers from 0% to 7% from Q1 FY26 to Q1 FY27, signaling healthy segment profitability.
Biosimilars revenue expands from ₹2,458 Cr to ₹2,855 Cr from Q1 FY26 to Q1 FY27, driving consistent top-line growth.
Consolidated R&D spend as a percentage of revenue holds steady at 7% from Q1 FY26 to Q1 FY27, reflecting disciplined investment.
Consolidated profit before tax margin falls from 7% to 3% from Q4 FY26 to Q1 FY27, indicating margin contraction.
Generics revenue declines from ₹851 Cr to ₹760 Cr from Q3 FY26 to Q1 FY27, signaling demand softening.
Generics EBITDA dips from ₹75 Cr to ₹56 Cr from Q4 FY26 to Q1 FY27, reflecting a post-peak adjustment.
Generics R&D margin drops from 11% to 6% from Q4 FY26 to Q1 FY27, showing reduced R&D intensity relative to sales.
Consolidated profit before tax falls from ₹328 Cr to ₹141 Cr from Q4 FY26 to Q1 FY27, highlighting earnings normalization.
BIOCON Analyst Rating
Buy
Analysts have suggested that investors can
Buy this Stock
- By Refinitiv from 16 analysts
Buy
50%
Hold
18.75%
Sell
31.25%
Get forecast for Price, ROA & ROE based on analyst ratings.
BIOCON Share Price History
BIOCON Fundamentals
Company Valuation
Market Cap (₹ Cr.)
57,805
PE Ratio
137.50
PB Ratio
1.66
Dividend Yield
0.14%
ROE
1.01%
ROCE
2.90%
Book Value (₹)
211.51
Face Value (₹)
5.00
Analyse BIOCON with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Dec 2025 | Jan 2026 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|
| Promoters | 54.45% | 44.91% | 44.91% | 44.68% | 44.68% |
| Domestic Institutional Investors (DII) | 21.71% | 24.16% | 24.07% | 23.38% | 29.30% |
| Foreign Institutional Investors (FII) | 7.39% | 7.14% | 7.52% | 8.14% | 8.64% |
| Public Investors | 12.38% | 10.23% | 10.01% | 10.26% | 10.19% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
Biocon Return Calculator
Note: Past profits do not guarantee future returns.
BIOCON Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
BIOCON Technicals
Moving Averages
Technical Indicators
Summary of Technical Indicators for BIOCON
Margin on BIOCON
*Calculated on NSE. Applicable on all exchanges. Margins are subject to change from time to time or may be withdrawn under volatile market conditions. Intraday Orders are square-off automatically at 03:19 pm on NSE / BSE or on hitting 80% of margin utilisation (whichever earlier).
BIOCON Financials Summary
In Crores
BIOCON Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Corporate Actions
The above dates are ex-dates.
Check BIOCON latest Company Filings, Investor Presentation & Conference Call details.
BIOCON Revenue Growth
All values are in Crores
Revenue
Profit
Loss
BIOCON Options Snapshot
BIOCON Futures Snapshot
Use from 12+ Pre-built Strategies or Build Your Own to trade BIOCON FnO contracts.
BIOCON Similar Stocks
FAQs on BIOCON
What is the share price of Biocon?
What is the 52W high and 52W low of Biocon?
What is the return on Biocon share?
- Past 1 year: -5.82%
- Past 3 years: 59.85%
- Past 5 years: 0.20%
What is the PE and PB Ratio of Biocon?
What is the EPS of Biocon?
What is the shareholding pattern of Biocon?
- DIIs - 29.30%
- FII - 8.64%
- Promoters - 44.68%
- Public Investors 10.19%
- Goverenment - 0.00%
How to buy Biocon shares online?
How to buy Biocon shares on Dhan?
- Download the Dhan App to Open a Demat Account
- Navigate to the “Money Tab”
- Add money to your account
- Search for Biocon share
- Tap on “Buy”
Option Chain